|
Real-time Estimate
Cboe Europe
09:15:16 2026-09-11 am EDT
|
5-day change | 1st Jan Change | ||
| 11,906.00 GBX | +1.26% |
|
-0.90% | -13.72% |
| 01:01am | Novartis investors turn spotlight on M&A after trial setbacks | RE |
| Sep. 10 | Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained | MT |
Chart: Technical Analysis
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
NYSE
| AZN | Delayed | |
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Berne S.E.
| 000982352 | End-of-day quote | |
Buenos Aires S.E.
| AZN | End-of-day quote | |
|
Buenos Aires S.E.
| AZND | End-of-day quote | |
Sao Paulo
| A1ZN34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 12,476 | 13,134 | 13,234 |
| Spread/Res. | -4.63% | -9.41% | -10.10% |
| Spread/Supp. | +3.82% | +3.82% | +3.82% |
| Support | 11,460 | 11,460 | 11,460 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
